F · Healthcare

BIOMED-LUBLIN WYT.SUR. (6NQ)

Biotechnology

BIOMED-LUBLIN WYT.SUR. (6NQ) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 6NQ

P/E ratio

25.00

BIOMED-LUBLIN WYT.SUR. (6NQ) — FAQ

What is 6NQ's P/E ratio?

The price-to-earnings (P/E) ratio for BIOMED-LUBLIN WYT.SUR. (6NQ) is 25.00 (data as of 2026-05-23).

Does BIOMED-LUBLIN WYT.SUR. pay a dividend?

Dividend yield is not available in the current snapshot for BIOMED-LUBLIN WYT.SUR. (6NQ). Check the MyAverix Finance app for the latest dividend data.

What sector is BIOMED-LUBLIN WYT.SUR. in?

BIOMED-LUBLIN WYT.SUR. (6NQ) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 6NQ listed on?

6NQ is listed on F.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)